State Street Corp Heron Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,192,436 shares of HRTX stock, worth $3.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,192,436
Previous 5,280,866 39.55%
Holding current value
$3.8 Million
Previous $18.5 Million 65.63%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.73 - $3.67 $3.61 Million - $7.66 Million
-2,088,430 Reduced 39.55%
3,192,436 $6.35 Million
Q2 2024

Aug 14, 2024
BUY
$2.32 - $3.86 $6.59 Million - $11 Million
2,839,996 Added 116.35%
5,280,866 $18.5 Million
Q1 2024

May 15, 2024
SELL
$1.71 - $3.06 $70,067 - $125,383
-40,975 Reduced 1.65%
2,440,870 $6.76 Million
Q4 2023

Feb 14, 2024
BUY
$0.54 - $1.82 $43,352 - $146,115
80,283 Added 3.34%
2,481,845 $4.22 Million
Q3 2023

Nov 14, 2023
BUY
$0.97 - $1.8 $68,214 - $126,583
70,324 Added 3.02%
2,401,562 $2.47 Million
Q2 2023

Aug 14, 2023
SELL
$1.11 - $2.88 $249,478 - $647,294
-224,755 Reduced 8.79%
2,331,238 $2.7 Million
Q1 2023

May 15, 2023
SELL
$1.51 - $3.25 $46,717 - $100,551
-30,939 Reduced 1.2%
2,555,993 $3.86 Million
Q4 2022

Feb 14, 2023
SELL
$2.25 - $4.67 $14.1 Million - $29.2 Million
-6,251,774 Reduced 70.73%
2,586,932 $6.47 Million
Q3 2022

Nov 15, 2022
SELL
$2.66 - $5.37 $19.9 Million - $40.2 Million
-7,490,090 Reduced 45.87%
8,838,706 $37.3 Million
Q2 2022

Aug 15, 2022
BUY
$2.3 - $6.29 $7.83 Million - $21.4 Million
3,405,427 Added 26.35%
16,328,796 $45.6 Million
Q1 2022

May 16, 2022
BUY
$4.63 - $9.94 $24.2 Million - $52 Million
5,230,958 Added 68.0%
12,923,369 $73.9 Million
Q4 2021

Feb 14, 2022
BUY
$8.35 - $12.6 $10 Million - $15.1 Million
1,200,504 Added 18.49%
7,692,411 $70.2 Million
Q3 2021

Nov 15, 2021
BUY
$10.13 - $15.0 $18 Million - $26.7 Million
1,779,188 Added 37.75%
6,491,907 $69.4 Million
Q2 2021

Aug 16, 2021
BUY
$13.27 - $18.48 $1.7 Million - $2.37 Million
128,420 Added 2.8%
4,712,719 $73.1 Million
Q1 2021

May 17, 2021
BUY
$14.49 - $20.72 $8.73 Million - $12.5 Million
602,495 Added 15.13%
4,584,299 $74.3 Million
Q4 2020

Feb 16, 2021
SELL
$14.61 - $22.14 $6.26 Million - $9.49 Million
-428,430 Reduced 9.71%
3,981,804 $84.3 Million
Q3 2020

Nov 10, 2020
BUY
$13.67 - $17.77 $7.79 Million - $10.1 Million
569,776 Added 14.84%
4,410,234 $65.4 Million
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $4.47 Million - $8.81 Million
410,333 Added 11.96%
3,840,458 $56.5 Million
Q1 2020

May 11, 2020
BUY
$10.23 - $24.56 $35.1 Million - $84.2 Million
3,430,125 New
3,430,125 $40.3 Million

Others Institutions Holding HRTX

# of Institutions
181
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $141M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email